Debate – Response Milestones that Matter in Chronic Myeloid Leukemia: MMR vs. CCyR
In view of the ongoing evolution of treatment goals, response milestones must be interpreted within the clinical context, and joint decision-making between patient and provider is important for treatment decisions, especially in ambiguous clinical situations. Expert-led education is needed to assist clinicians with the effective implementation of these strategies into their routine clinical practice.
Category
  • Chronic Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation